60 Degrees Pharmaceuticals (SXTP) Asset Utilization Ratio (2023 - 2026)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Asset Utilization Ratio of 0.17 for Q1 2026, up 46.0% year-over-year from 0.11 in Q1 2025, and down 0.75% quarter-over-quarter from 0.17 in Q4 2025.
60 Degrees Pharmaceuticals (SXTP) Asset Utilization Ratio (2023 - 2026) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Asset Utilization Ratio for 4 consecutive years, with 0.17 the latest figure, recorded in Q1 2026.
- In Q1 2026, Asset Utilization Ratio rose 46.0% year-over-year to 0.17; the TTM figure through Mar 2026 stood at 0.17 (up 46.0% YoY), while the FY2025 annual figure was 0.18, up 101.45% from the prior year.
- Asset Utilization Ratio retreated to 0.17 in Q1 2026 per SXTP's latest filing, from 0.17 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.17 in Q3 2025 and bottomed at 0.06 in Q3 2023.
- Historically, Asset Utilization Ratio has averaged 0.12 across 4 years, with a median of 0.11 in 2024.
- On a YoY basis, Asset Utilization Ratio climbed as much as 91.47% in 2024 and fell as far as 5.5% in 2024.
- 60 Degrees Pharmaceuticals' Asset Utilization Ratio stood at 0.09 in 2023, then increased by 5.5% to 0.09 in 2024, then jumped by 80.93% to 0.17 in 2025, then fell by 0.75% to 0.17 in 2026.
- Business Quant data shows SXTP's Asset Utilization Ratio at 0.17 in Q1 2026, 0.17 in Q4 2025, and 0.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.77 Bn | 131.91 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 65.36 Bn | 60.17 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.60 Bn | 54.47 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn | 0.90 |
| 7 | BioNTech SE | 28.13 Bn | 9.73 Bn | 668.28 Mn | 0.13 |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 0.54 |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 0.13 |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | 0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.17 |
| Dec 31, 2025 | 0.17 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.13 |
| Mar 31, 2025 | 0.11 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.09 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.06 |